Responses of the yeast genes encoding 3-hydroxy-3-methylglutaryl coenzyme A reductase, HMGI and HMG2, to in vivo changes in heme concentrations were investigated. Expression of the genes was determined by direct measurement of the mRNA transcribed from each gene, by direct assay of the enzyme activity encoded by each gene, and by measurement of the expression of lacZ fusions to the control regions of each gene. These studies indicated that expression of HMGI was stimulated by heme, whereas expression of HMG2 was repressed by heme. The effect of heme on HMG1 expression was mediated by the HAPI transcriptional regulator and was independent of HAP2. Thus, the genes encoding the 3-hydroxy-3-methylglutaryl coenzyme A reductase isozymes join a growing list of gene pairs that are regulated by heme in opposite ways.
In the yeast Saccharomyces cerevisiae, expression of a number of genes is regulated by the level of oxygen in the environment. Many of the genes whose expression is regulated by oxygen encode proteins involved in cellular respiration, such as the cytochromes (15, 21, 50, 55) . Other oxygen-regulated genes include PUT], which encodes a component of the oxygen-dependent proline utilization pathway (54) as well as several genes of unknown function (29) . Oxygen increases the expression of some genes and decreases the expression of others (29, 51) . In several cases, the effects of oxygen on gene expression are mediated by heme, a molecule whose synthesis requires molecular oxygen (33) . Three genes, HAP) (CYPJ), HAP2, and HAP3, encode transcription factors that serve to activate the expression of a number of oxygen-regulated genes (39) (40) (41) . The ability of HAP) to activate transcription is heme dependent (15, 17, 53) . The REOJ and ROXI genes encode proteins that act to repress the expression of genes in aerobically grown cells (28, 30, 50) . Thus, expression of oxygen-regulated genes is controlled by a set of oxygensensitive transcription factors.
In addition to respiration, another cellular function that occurs only in aerobically growing cells is the biosynthesis of sterols. Certain steps in the sterol biosynthetic pathway require heme and molecular oxygen (13, 19) . In many organisms, sterol biosynthesis is controlled in part by regulating the activity of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, which catalyzes the rate-limiting step in sterol biosynthesis (reviewed in reference 8). HMGCoA reductase activity has been reported to be higher in aerobically grown cells than in anaerobically grown cells (7, 43) . Studies with the yeast S. cerevisiae found HMG-CoA reductase activity to be lower in heme-deficient cells than in heme-sufficient cells, suggesting that heme acts as a positive regulator of HMG-CoA reductase (27) . Since heme can act as a signal of oxygen levels in yeast cells, heme levels may mediate the effect of oxygen on the expression of the HMG-CoA reductase genes. * Yeast cells contain two structural genes for HMG-CoA reductase, HMGI and HMG2 (6) . Yeast genes that occur in pairs often have different patterns of regulation. In this study, the effect of heme levels on expression of the two isozymes of HMG-CoA reductase was evaluated by using lacZ gene fusions to HMGI and HMG2. The regulation of the intact HMG-CoA reductase genes was also monitored by mRNA analysis and HMG-CoA reductase assays. The results indicated that heme levels mediated transcriptional control of HMG) and HMG2 and that heme stimulated expression of HMGI and decreased expression of HMG2. Strains. The yeast strains used are described in Table 1 . Plasmid pTPheml::LEU2 (42) was used to introduce the heml::LEU2 disruption mutation into JRY438 by one-step gene disruption methods (46) . The predicted structure of the disrupted HEM) locus in the resulting strain, JRY1236, was confirmed after disruption by a gel transfer hybridization experiment.
Strains carrying the heml: :LEU2 disruption were used to study the role of heme in the expression of the HMG1 and HMG2 genes. The HEM) gene encodes the enzyme 8-aminolevulinate synthase, and the heml::LEU2 disruption blocks the synthesis of the heme precursor 5-ALA. Supplementation of media with either a low (0.5 p.g/ml) or a high (50 jig/ml) concentration of 5-ALA allowed growth of hem) strains. However, cells grown in low 5-ALA were heme deficient, whereas cells grown in high 5-ALA were heme sufficient (42) .
The effect of the heml::LEU2 mutation on HMG) and HMG2 expression was determined by using the HMGI-lacZ and HMG2-lacZ gene fusions. The heml::LEU2 mutation was introduced into strains carrying these lacZ fusions as (5, 44) , was isolated and inserted into the HindIII-SphI sites of the polylinker of pEMBL18 (provided by R. Levis [12] ) to generate plasmid pJR420. Next, the 3.0-kbp Sall fragment carrying the Escherichia coli lacZ gene was isolated from pMC1871 (9) and inserted into the Sall site of pJR420 to generate plasmid pJR425. This insertion created an in-frame fusion between HMGJ and lacZ at the first ATG of the HMGJ coding sequence. Plasmid pJR425 was then cut with HindIll and XbaI, liberating a 4.1-kbp HMGI-lacZ fusion fragment, and treated with the Klenow fragment of E. coli DNA polymerase I to make the ends flush. The HMGJ-lacZ fragment was inserted into plasmid pJR422, which had been linearized by cutting with BamHI and treated with the Klenow fragment of E. coli polymerase I to make the ends flush. The resulting centromere plasmid, pJR436, carried the HMGJ-lacZ fusion immediately followed by the CYCI transcription terminator (Fig. 1A) . The sequence of the fusion junction between HMGJ and lacZ was verified by sequencing across the junction by using the universal primer, which hybridized to lacZ near the fusion junction (47) .
For construction of pJR502, an integrating plasmid carrying the HMGJ-lacZ fusion at the first ATG of HMGJ, plasmid pJR436 was cut to completion with HindIll and then partially digested with SphI. A 4.55-kbp SphI-HindIII fragment containing the HMGJ-IacZ-TERM fusion was isolated and inserted into the HindIII-SphI sites of plasmid YIp5 (49) to generate pJR502 (Fig. 1B) (34) . Assays were done on 1.5-ml portions in duplicate from several transformants for each plasmid under each condition. Units were normalized to cell density. In strains containing either multicopy plasmids or integrated lacZ fusions, the activity assays agreed within 15%. In the case of centromere plasmids containing lacZ fusions, the activity levels varied by as much as a few fold among isogenic transformants, presumably because of variation in copy number (45) . Therefore, the integrated and multicopy plasmids were used for all experiments reported.
Preparation of cell extracts. Cell cultures (50 Analysis of yeast mRNA. Yeast mRNA was isolated as described previously (52) . Aerobic cultures (100 ml) were grown in YM and harvested during logarithmic growth. Poly(A)+ RNA was isolated by oligo(dT)-cellulose chromatography, with minor modifications of a previously described procedure (2) . Poly(A)+ RNA samples were analyzed by gel transfer hybridization analysis (32) . Quantitative estimates of the abundance of individual mRNA species were based upon multiple exposures of autoradiograms and, in some cases, comparisons of band intensities resulting from loading different amounts of RNA.
Analysis of yeast genomic DNA. Yeast genomic DNA was prepared as described previously (22) . The DNA was digested to completion with the indicated restriction enzymes and evaluated by a gel transfer hybridization analysis (32) . RESULTS HMGI-lacZ fusion constructions. Two different fusions of lacZ to the HMGJ promoter and 5' untranslated region were constructed. In the first, the fusion junction between HMGJ and lacZ was at an SphI site that overlaps the first ATG of the HMGJ coding sequence. Therefore, this fusion contained the HMGJ promoter and 5' untranslated sequences but contained no HMG1 protein-coding sequences. This fusion was introduced into yeast cells both on a centromere plasmid and integrated into the yeast chromosome at HMGJ. The structure of the fusion integrated at HMGJ is shown in Fig. 1C . The integration at HMGJ created a URA3 strain that precluded the opportunity to select for the propagation of URA3-marked plasmids.
Evaluation of HMGI-lacZ and HMG2-lacZ fusions. Plasmid pJR436 carried the fusion of lacZ to the first ATG of HMGJ on the yeast centromere vector YCp5O, which is maintained at one to two copies per cell. The expression of HMGI-lacZ on YCp5O was promoted by a 0.95-kbp HMGJ promoter fragment, whereas expression of the fusion integrated at HMGJ was promoted by all of the chromosomal sequences normally upstream of HMGJ. Levels of expression of the chromosomal and plasmid-borne fusions were similar ( Table  2 ), suggesting that the 0.95-kbp HMGJ promoter fragment present on pJR436 contained all sequences necessary for normal HMGJ expression. There were, however, slight differences in expression of the fusion in these two contexts. Expression of the fusion on the plasmid YCp5O was somewhat more variable than expression of the fusion integrated into the chromosome, presumably because of copy number variations of the plasmid in different populations of cells.
Since the HMGJ open reading frame contained a second in-frame ATG codon 10 codons 3' of the first ATG, there was some ambiguity regarding whether fusions to the first ATG would measure all expression of the HMGJ gene (24) . Therefore, a fusion was made of lacZ to a restriction site placed after the second ATG by methods similar to those described above. Since this construction produced signifi- cantly less 3-galactosidase activity than did the fusion to the first ATG (unpublished observations), the protein produced from the fusion to the first ATG presumably reflects all of the expression from the HMGJ gene. Plasmid pJR550 carried a fusion of lacZ to the HMG2 promoter and 5' untranslated sequences on the yeast multicopy plasmid YEp24. Strains carrying the fusion typically expressed 0.5 to 1.0 U of P-galactosidase activity. Since an integrated HMG2-lacZ fusion would be expected to produce even lower levels of ,-galactosidase activity, the experiments with an HMG2-lacZ fusion all used plasmid pJR550.
Heme depletion and lacZ fusion expression. The effect of heme depletion on expression of the HMGI-lacZ and HMG2-lacZ fusions was tested. Heme depletion had opposite effects on the expression of the two fusions: expression of HMGI-lacZ was decreased, whereas expression of HMG2-lacZ was increased ( ever, HMGI-IacZ expression in both HEM] and hemi strains had returned to wild-type levels. The rate of induction of HMG2-lacZ expression upon shift from high-b-ALA medium to low-b-ALA medium was also examined (Fig. 2B) . In a hemi strain, induction of HMG2 expression began within 2 h after the shift and was essentially complete at 12 h after the shift. Expression of HMG2-lacZ in a HEM] strain was not affected by the shift to low-b-ALA medium. Judging from the rapidity of HMG2 induction, hem] cells were apparently depleted of heme fairly quickly after the shift to low-b-ALA medium.
HMG1 and HMG2 mRNA levels in a hem] mutant. The effect of heme starvation on HMG-CoA reductase mRNA levels was examined by analyzing poly(A)+ RNA obtained from the hemi strain JRY2092 and the HEM] strain JRY2093, each grown in both high-and low-b-ALA media. A 2.46-kbp fragment of the HMGJ gene was used as a probe in an RNA gel transfer hybridization experiment (Fig. 3) . This probe hybridized to a 3.25-kbp mRNA in HMGJ strains but did not detect a cross-hybridizing mRNA in JRY1159, which carried the hmgl::LYS2 disruption. The probe was thus specific for the HMGJ message. The steady-state level of the HMGJ message was lower in hem] strains than in HEM] strains. This reduction in the HMGJ message level was greater in cells grown in low-b-ALA medium but was apparent even in hemi strains grown in high-b-ALA medium, again suggesting that hemi cells grown in high-b-ALA medium were somewhat depleted of heme. On the whole, these data indicated that the reduced expression of the HMGIlacZ fusion in heme-starved cells was caused primarily by changes in the steady-state level of the HMGJ message.
The effect of the hemi mutation on the steady-state level of HMG2 mRNA was examined by hybridizing a 1.0-kbp fragment of the HMG2 gene to the same filter used in the previous RNA gel transfer hybridization experiment. This probe hybridized to a 3.2-kbp mRNA in strains that carried a wild-type HMG2 allele and was missing in JRY1160, which carried the hmg2::HIS3 disruption (Fig. 4) . Thus, the probe was specific for the HMG2 message. A 1.9-kbp mRNA was abundant in cells that carried the hmg2::HIS3 disruption and presumably represented a polyadenylated RNA species produced from the hmg2::HIS3 allele. The steady-state level of HMG2 message was greater in a heml mutant strain than in a HEM] strain, and the level of HMG2 message in hem] cells was reduced by growth in high-b-ALA medium. It was strikingly evident, however, that the extent of induction of HMG2 mRNA was not nearly as great as the induction of ,-galactosidase activity expressed from HMG2-lacZ. Indeed, HMG2 message levels in hem) strains grown in low-b-ALA medium were approximately threefold higher than in a HEM) strain (unpublished observations), whereas ,-galactosidase activity from HMG2-lacZ was typically 100-fold higher under these conditions. The quantitative difference between the results of the two assays was surprising and is discussed below. These results suggested that heme levels regulated the expression of HMG2 at the transcriptional level, with higher heme levels leading to decreased expression. The HMG2-lacZ fusion provided a qualitatively reliable, but quantitatively imprecise, monitor of influences on HMG2 expression.
HMG-CoA reductase activity in hem] cells. In mammals, HMG-CoA reductase activity is regulated by both transcriptional and posttranscriptional mechanisms. Therefore, it was important to determine whether the effects of heme level on HMGI and HMG2 transcription were paralleled by changes in enzyme activity. The effect of heme depletion on total cellular HMG-CoA reductase activity was studied in strains carrying the heml: :LEU2 mutation. A diploid heterozygous for heml: :LEU2 was made by mating JRY527 with JRY1236. The two HEM) and two hem) segregants from one tetrad of this diploid were grown in low-b-ALA medium, and the specific activity of HMG-CoA reductase in cell extracts was determined. The specific activity of HMG-CoA reductase in the two heml segregants was the same as in the two HEM) segregants ( Table 4 ), indicating that heme depletion did not alter total cellular HMG-CoA reductase activity. These four strains had the same specific activity of HMG-CoA reductase when grown in high-b-ALA medium (data not shown). Since heme depletion had opposite effects on the expression of HMGJ and HMG2, it was essential to distinguish the effects of heme depletion on the activity of the HMG1 and HMG2 isozymes. The influence of heme concentration on the enzymatic activities encoded by the two genes was determined by assaying HMG-CoA reductase activity in strains carrying either the hmgl::LYS2 or the hmg2::HIS3 allele.
The effect of heme depletion on the activity of the HMG1 isozyme was studied in segregants from a diploid heterozygous for heml ::LEU2 and homozygous for hmg2::HIS3 (JRY1160 x JRY2108). The four spore clones from one tetrad of this cross were grown in low-B-ALA medium, and the HMG-CoA reductase activity was determined. HMGCoA reductase activity was 10-fold lower in the hemi segregants than in the HEM] segregants. HMGI-derived HMG-CoA reductase activity in the hem) strain was restored to wild-type levels when cells were grown in highb-ALA medium (data not shown). The magnitude of the change in the activity of the HMG1 isozyme in hemedepleted cells correlated well with both the change in expression of the HMGI-lacZ fusion and the change in the level of HMGJ mRNA. These data extended the conclusion that heme was a positive regulator of HMGJ expression and that the induction of HMGI-dependent activity occurred at the level of mRNA accumulation.
The effect of heme depletion on the activity of the HMG2 isozyme was studied in strains with the hmgl::LYS2 allele and the heml::LEU2 allele. For this experiment, the four spore clones from one complete tetrad from a diploid heterozygous for the heml: :LEU2 disruption and homozygous for hmgl::LYS2 (JRY1159 x JRY2098) were grown in lowb-ALA medium, and the HMG-CoA reductase activity was determined. Under these growth conditions, the activity of the HMG2 isozyme was two-to threefold higher in the hem) strains than in the HEM) strains (Table 4) . HMG-CoA reductase activity derived from the HMG2 isozyme was restored to wild-type levels when the hem) strain was grown in high-b-ALA medium (data not shown). The induction of HMG-CoA reductase activity correlated well in magnitude with the induction of HMG2 mRNA in hem) strains grown in low-b-ALA medium. Thus, heme depletion caused a threefold increase in HMG2 message level, and this increase resulted in a comparable increase in HMG-CoA reductase activity contributed by the HMG2 isozyme. Because of the quantitative agreement between the analysis of HMG2 mRNA and enzyme activity, the magnitude of the HMG2-lacZ induction was considered artifactually high.
Roles of HAP1 and HAP2 in HMG-CoA reductase gene expression. The HAP) gene product mediates the effects of heme and oxygen levels on transcription of several yeast genes. In addition, HAP2 participates in expression of some heme-regulated genes (14) . The HMGl-lacZ and HMG2-lacZ fusions were used to determine whether the HAP) and HAP2 genes also regulated the expression of HMGJ and HMG2. The lacZ fusion plasmids pJR502 (HMGI-lacZ; linearized by cleavage with BglII) and pJR550 (HMG2-lacZ) were transformed into a HAP] HAP2 strain (BWG1-7a), a hapl::LEU2 HAP2 strain (BWG1-7a hapl::LEU2), and a HAP) hap2::LEU2 strain (BWG1-7a hap2::LEU2). All strains transformed with the HMGI-lacZ fusion were shown to have a single copy of the HMGl-lacZ fusion integrated at HMGJ by a gel transfer hybridization experiment (data not shown). Expression of HMGI-lacZ was reduced 20-to 30-fold in a strain carrying the hapl: :LEU disruption ( Table  5) . The level of ,-galactosidase activity in this hapl::LEU2 strain was comparable to the activity in a heml::LEU2 strain, suggesting that the effect of heme on HMG) transcription was mediated by the HAP1 protein. In contrast, the hapl::LEU2 disruption caused a twofold increase in the expression of HMG2-lacZ. The magnitude of the increase in HMG2-lacZ expression in the hap) strain was much lower than in the hem) strain. The significance of this slight increase was unclear. The hap2::LEU2 disruption caused a twofold increase in the expression of HMGI-lacZ and had no effect on the expression of HMG2-lacZ. The small effect of the hap2 mutation on expression of HMG) suggested that HAP2 did not play a major role in the regulation of HMGCoA reductase gene expression.
Heme independence of acetoacetyl-CoA thiolase and HMGCoA synthase expression. Studies with mammalian cells have provided evidence that the first three enzymes of the sterol biosynthetic pathway, acetoacetyl-CoA thiolase, HMG-CoA synthase, and HMG-CoA reductase, are coordinately regulated (10, 11) . There is suggestive evidence that these enzymes are also coordinately regulated in yeast cells (48) . Two experiments were performed to address whether the regulation of acetoacetyl-CoA thiolase and HMG-CoA synthase activity was also influenced by heme. The effect of heme depletion on the steady-state level of HMG-CoA synthase mRNA was examined by an RNA gel transfer hybridization experiment. A 2.2-kbp fragment of the HMGCoA synthase gene (ERG13; from pSOC481, provided by K. Jarman and J. Proffitt, Amoco Corp.) was hybridized to the filter used in the experiments shown in Fig. 3 and 4 . This probe detected a 1.6-kbp HMG-CoA synthase mRNA. The steady-state level of this mRNA was reduced approximately twofold in a hem) mutant strain relative to the level in a wild-type strain. However, the level of the HMG-CoA synthase mRNA in the hem) strain was not affected by the concentration of b-ALA in the medium (data not shown). To determine whether this slight reduction in message level was biochemically significant, the levels of HMG-CoA synthase and acetoacetyl-CoA thiolase activity were measured in HEM) and hem) strains. The assays revealed no effect of the hem) mutation on either of these activities ( matic increase in ,-galactosidase activity produced from the HMG2-lacZ fusion. Thus, in heme-deficient hemi cells, there was excellent quantitative and qualitative agreement between the increases in HMG2-derived HMG-CoA reductase enzyme activity and HMG2 mRNA levels and a qualitative agreement with the HMG2-lacZ fusion expression. Repression by heme was HAP] and HAP2 independent, which was not surprising since these two genes encode known transcriptional activators. The reason for the discrepancy between the magnitude of the HMG2::lacZ induction and the magnitude of the enzyme and mRNA induction is unclear. It is unlikely that differences between the half-lives of HMG2 protein and 3-galactosidase could account for the discrepancy, since the induction of HMG2 mRNA corresponds in magnitude to the induction of enzyme activity.
Furthermore, the P-galactosidase produced from the HMG2:: lacZ gene was unlikely to be more stable than that produced from the HMGI ::lacZ gene. It was possible, however, that the HMG2::lacZ mRNA was much more stable than the HMG2 mRNA, thus leading to a disproportionate induction of 3-galactosidase activity.
The opposing effects of heme levels on the expression of the two HMG-CoA reductase genes were not indirect effects caused by changes in HMG-CoA reductase activity. Null alleles of HMGJ had no effect on HMG2 expression and vice versa. Furthermore, both induction of HMG2 expression and loss of HMGJ expression in response to changes in heme level could occur in the absence of the other isozyme. Thus, the effects of heme on expression of each isozyme were independent of effects on the other isozyme. The involvement of HAP] in HMGJ transcription suggested that the effect of heme levels on HMGJ expression was direct.
However, it remains possible that HAP] controlled another gene that was responsible for HMGJ transcription. There was no information that would indicate whether the effect of heme on HMG2 was direct or was indirect due to some other effect of heme deficiency.
Although heme did modulate the expression of the HMGJ and HMG2 genes and the activities of the HMG1 and HMG2 isozymes, heme depletion did not affect the total cellular activity of HMG-CoA reductase. In fact, the pattern of the heme-mediated effects acted to buffer against changes in the total HMG-CoA reductase activity level. The lack of an effect on total cellular HMG-CoA reductase activity by heme depletion is in apparent conflict with an earlier report of heme depletion resulting in a substantial decrease in HMGCoA reductase activity (27) . There are important differences between the experiments reported here and the earlier ones that may explain this discrepancy. In this work, hemedeficient cells were produced by growth of a hemi mutant on low-8-ALA medium, whereas in the earlier study hemedeficient cells were produced by growing a hemi mutant in the complete absence of heme (supplemented with ergosterol, unsaturated fatty acids, and methionine). In particular, the presence or absence of ergosterol in the growth medium may have affected HMG-CoA reductase activity. (36) . The side chain of heme a, a cofactor of cytochrome c oxidase, is also derived from farnesyl pyrophosphate (23) . The demand for both of these products would be higher during aerobic growth, with high heme levels, than during semianaerobic growth, with low heme levels. Perhaps the two genes respond differently to demands for different products of the pathway.
In some respects, the transcriptional regulation of the yeast HMG-CoA reductase genes by heme parallels the transcriptional regulation of mammalian HMG-CoA reductase genes by low-density lipoprotein. Circulatory lowdensity lipoprotein levels reflect the available supply of cholesterol to individual cells in mammals. The yeast S. cerevisiae, being a unicellular eucaryote, in all probability does not respond to the level of sterols in its niche. Rather, yeast cells may monitor intracellular sterol levels. Molecular oxygen is required both in heme biosynthesis and in two steps of sterol biosynthesis, cyclization of squalene and demethylation of lanosterol. Oxygen level may therefore be an effective monitor of the availability of sterols. Thus, transcriptional control of HMG-CoA reductase by lowdensity lipoproteins in mammals and by heme in yeast cells may reflect similar biological needs. To 
